Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Exercise Test × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Breast 11 Thoracic 8 Other hematologic neoplasm 7 Lymphoid 6 Genitourinary 5 Other solid neoplasm 4 Gynecologic 4 Other 3 Plasma cell 2 Other neoplasm 1 Myeloid 1 Head & Neck 1 Endocrine 1 Dermatologic 1

Conditions

Melanoma 1 Carcinoma, Merkel Cell 1

Interventions

Nivolumab 140 pembrolizumab 125 Ipilimumab 125 Cyclophosphamide 109 aldesleukin 59 Radiotherapy 59 Interleukin-2 58 fludarabine phosphate 55 Biopsy 45 Blood Specimen Collection 39 fludarabine 38 Temozolomide 37 Radiosurgery 37 Peripheral Blood Stem Cell Transplantation 37 trametinib 35 Vemurafenib 32 dabrafenib 30 sargramostim 29 Bevacizumab 28 Magnetic Resonance Spectroscopy 27 Aminolevulinic Acid 26 Surveys and Questionnaires 24 Photochemotherapy 24 Imiquimod 24 Specimen Handling 23 Mycophenolic Acid 23 Whole-Body Irradiation 22 Introns 22 Cyclosporine 22 Melphalan 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06008977 2025-06-04

EX-BOOST

AdventHealth Translational Research Institute

Phase NA Recruiting

Melanoma, Carcinoma, Merkel Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡